Title:
ANTI-HUMAN NERVE GROWTH FACTOR ANTIBODY
Document Type and Number:
WIPO Patent Application WO/2021/208928
Kind Code:
A1
Abstract:
Provided are a neutralizing antibody or an antigen-binding fragment thereof which specifically binds to an NGF, and a preparing method for producing this antibody. Also provided is an application of this antibody in treating diseases related to the NGF, and especially in relieving or improving individual pain.
Inventors:
LIAO HUAXIN (CN)
ZHENG WEIHONG (CN)
WANG XIAOLI (CN)
WANG YUEMING (CN)
GONG HUIZHEN (CN)
LIANG JUNLANG (CN)
ZHENG WEIHONG (CN)
WANG XIAOLI (CN)
WANG YUEMING (CN)
GONG HUIZHEN (CN)
LIANG JUNLANG (CN)
Application Number:
PCT/CN2021/087015
Publication Date:
October 21, 2021
Filing Date:
April 13, 2021
Export Citation:
Assignee:
ZHUHAI TRINOMAB BIOTECHNOLOGY CO LTD (CN)
International Classes:
C07K16/22; A61K39/395; A61P25/04; C12N5/16; C12N15/13; C12N15/63; G01N33/53
Foreign References:
CN102762228A | 2012-10-31 | |||
CN104910274A | 2015-09-16 | |||
EP2364728A1 | 2011-09-14 |
Attorney, Agent or Firm:
ZHONGZI LAW OFFICE (CN)
Download PDF:
Previous Patent: ANTI-HUMAN NERVE GROWTH FACTOR ANTIBODY
Next Patent: METHOD FOR DETERMINING BACTERIAL COMPOSITION OF VAGINAL MICROBIOME
Next Patent: METHOD FOR DETERMINING BACTERIAL COMPOSITION OF VAGINAL MICROBIOME